BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31955429)

  • 1. Nutritional ketosis improves exercise metabolism in patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Bleeker JC; Visser G; Clarke K; Ferdinandusse S; de Haan FH; Houtkooper RH; IJlst L; Kok IL; Langeveld M; van der Pol WL; de Sain-van der Velden MGM; Sibeijn-Kuiper A; Takken T; Wanders RJA; van Weeghel M; Wijburg FA; van der Woude LH; Wüst RCI; Cox PJ; Jeneson JAL
    J Inherit Metab Dis; 2020 Jul; 43(4):787-799. PubMed ID: 31955429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of acute nutritional ketosis during exercise in adults with glycogen storage disease type IIIa are phenotype-specific: An investigator-initiated, randomized, crossover study.
    Hoogeveen IJ; de Boer F; Boonstra WF; van der Schaaf CJ; Steuerwald U; Sibeijn-Kuiper AJ; Vegter RJK; van der Hoeven JH; Heiner-Fokkema MR; Clarke KC; Cox PJ; Derks TGJ; Jeneson JAL
    J Inherit Metab Dis; 2021 Jan; 44(1):226-239. PubMed ID: 33448466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac tissue citric acid cycle intermediates in exercised very long-chain acyl-CoA dehydrogenase-deficient mice fed triheptanoin or medium-chain triglyceride.
    Gaston G; Gangoiti JA; Winn S; Chan B; Barshop BA; Harding CO; Gillingham MB
    J Inherit Metab Dis; 2020 Nov; 43(6):1232-1242. PubMed ID: 33448436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
    Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
    Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered Energetics of Exercise Explain Risk of Rhabdomyolysis in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency.
    Diekman EF; Visser G; Schmitz JP; Nievelstein RA; de Sain-van der Velden M; Wardrop M; Van der Pol WL; Houten SM; van Riel NA; Takken T; Jeneson JA
    PLoS One; 2016; 11(2):e0147818. PubMed ID: 26881790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutrition management guideline for very-long chain acyl-CoA dehydrogenase deficiency (VLCAD): An evidence- and consensus-based approach.
    Van Calcar SC; Sowa M; Rohr F; Beazer J; Setlock T; Weihe TU; Pendyal S; Wallace LS; Hansen JG; Stembridge A; Splett P; Singh RH
    Mol Genet Metab; 2020; 131(1-2):23-37. PubMed ID: 33093005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
    Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
    PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
    Tucci S; Behringer S; Spiekerkoetter U
    FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial.
    Ørngreen MC; Madsen KL; Preisler N; Andersen G; Vissing J; Laforêt P
    Neurology; 2014 Feb; 82(7):607-13. PubMed ID: 24453079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proposal for an individualized dietary strategy in patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Bleeker JC; Kok IL; Ferdinandusse S; de Vries M; Derks TGJ; Mulder MF; Williams M; Gozalbo ER; Bosch AM; van den Hurk DT; de Sain-van der Velden MGM; Waterham HR; Wijburg FA; Visser G
    J Inherit Metab Dis; 2019 Jan; 42(1):159-168. PubMed ID: 30740737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
    MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
    J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation.
    Behrend AM; Harding CO; Shoemaker JD; Matern D; Sahn DJ; Elliot DL; Gillingham MB
    Mol Genet Metab; 2012 Jan; 105(1):110-5. PubMed ID: 22030098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impairment of mitochondrial bioenergetics and permeability transition induction caused by major long-chain fatty acids accumulating in VLCAD deficiency in skeletal muscle as potential pathomechanisms of myopathy.
    Cecatto C; Amaral AU; Roginski AC; Castilho RF; Wajner M
    Toxicol In Vitro; 2020 Feb; 62():104665. PubMed ID: 31629068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency.
    Diekman EF; Ferdinandusse S; van der Pol L; Waterham HR; Ruiter JP; Ijlst L; Wanders RJ; Houten SM; Wijburg FA; Blank AC; Asselbergs FW; Houtkooper RH; Visser G
    Genet Med; 2015 Dec; 17(12):989-94. PubMed ID: 25834949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle MRI in patients with long-chain fatty acid oxidation disorders.
    Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G
    J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
    Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of resveratrol on fatty acid oxidation or exercise capacity in patients with fatty acid oxidation disorders: A randomized clinical cross-over trial.
    Storgaard JH; Løkken N; Madsen KL; Voermans NC; Laforêt P; Nadaj-Pakleza A; Tard C; van Hall G; Vissing J; Ørngreen MC
    J Inherit Metab Dis; 2022 May; 45(3):517-528. PubMed ID: 35066899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic and muscular effects of different dietary fat content in VLCAD deficient mice.
    Primassin S; Tucci S; Spiekerkoetter U
    Mol Genet Metab; 2011 Dec; 104(4):546-51. PubMed ID: 21963783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very long-chain acyl-coenzyme A dehydrogenase deficiency in Chinese patients: eight case reports, including one case of prenatal diagnosis.
    Li X; Ding Y; Ma Y; Liu Y; Wang Q; Song J; Yang Y
    Eur J Med Genet; 2015 Mar; 58(3):134-9. PubMed ID: 25652019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Metabolic Flexibility in Inherited Metabolic Diseases of Mitochondrial Fatty Acid Metabolism.
    Tucci S; Alatibi KI; Wehbe Z
    Int J Mol Sci; 2021 Apr; 22(7):. PubMed ID: 33917608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.